JAMA Network OpenPeer-Reviewed Publication JAMA Network About The Study: In this randomized clinical trial that compared a brief outpatient rehabilitation program with a cognitive and behavioral approach with usual care in 314 patients with post–COVID-19 condition, self-reported physical function improved statistically and clinically significantly in the intervention group after 2 to 8 outpatient encounters. The effect...
Tag: <span>COVID-19</span>
Post
Exploring role of understudied dysfunctional immune cells in severe COVID-19
by Trinity College Dublin Credit: JCI Insight (2024). DOI: 10.1172/jci.insight.171659 At the beginning of the COVID-19 pandemic, numerous studies had shown that COVID-19 patients with high levels of neutrophils, a key immune cell, presented with more severe disease and poor clinical outcomes. It was not clearly understood how or why this was happening. A recently published study from...
Post
Data: COVID-19 activity is high in New Mexico
By KOBDecember 16, 2024 – 2:16 PM ALBUQUERQUE, N.M. — Data from the Centers for Disease Control and Prevention and the New Mexico Department of Health is showing high COVID-19 activity in our state. The CDC tests wastewater to detect traces of several infectious diseases, including COVID. According to data from wastewater sites in Bernalillo County...
Post
Study finds 70% of young people with long COVID recover within two years
by University College London Credit: Unsplash/CC0 Public Domain Most young people who were confirmed to have long COVID three months after a positive PCR test had recovered within 24 months, finds a study led by UCL researchers. The Children and young people with Long COVID (CLoCK) study, published in Nature Communications Medicine, is the world’s largest longitudinal...
Post
Risk of post-COVID symptoms linked to body mass index in children
by Justin Jackson , Medical Xpress Credit: Unsplash/CC0 Public Domain A study by the University of Pennsylvania and researchers from 26 U.S. children’s hospitals has linked elevated body mass index (BMI) to a significantly higher risk of developing post-acute sequelae of SARS-CoV-2 infection (PASC) among children and young adults. The study revealed a 25.4% increased...
Post
Montelukast doesn’t cut time to COVID symptom relief, clinical trial finds
by Mary Van Beusekom, University of Minnesota Credit: JESHOOTS.com from Pexels A 14-day course of the oral anti-inflammatory drug montelukast didn’t shorten symptom duration in nonhospitalized US adults with mild or moderate COVID-19, finds a randomized controlled clinical trial published today in JAMA Network Open. The Accelerating COVID-19 Therapeutic Interventions and Vaccines-6 (ACTIV-6) Study Group and Investigators randomly assigned...
Post
New study reveals long-term brainstem damage in COVID-19 survivors using advanced MRI scans
Study: Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations. Image Credit: Silver Place/Shutterstock.com A recent study published in Brain performed ultrahigh field quantitative susceptibility mapping (QSM) of the brainstem in coronavirus disease 2019 (COVID-19) survivors post-hospitalization. Introduction Neuroradiological changes have been reported in hospitalized COVID-19 patients. Cerebral microhemorrhages, white matter hyperintensities, and encephalopathy are...
Post
History of COVID-19 found to double long-term risk of heart attack, stroke and death
A history of COVID-19 can double the risk of heart attack, stroke or death according to new research led by Cleveland Clinic and the University of Southern California. The study found that people with any type of COVID-19 infection were twice as likely to have a major cardiac event, such as heart attack, stroke or even...
Post
Newly discovered COVID vaccine targets may last longer
Workflow for the generation of SARS-CoV-2-derived HLA I and HLA II immunopeptidome data. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-51959-6 Melbourne researchers have discovered more than 200 new vaccine target candidates from the COVID-19 virus, SARS-CoV-2, that could lead to the development of vaccines with a longer lasting broader immunity than existing vaccinations. In a paper published in the journal Nature...
Post
Understanding symptoms: Is it hay fever, COVID or something else?
Hay fever (also called allergic rhinitis) affects 24% of Australians. Symptoms include sneezing, a runny nose (which may feel blocked or stuffy) and itchy eyes. People can also experience an itchy nose, throat or ears. But COVID is still spreading, and other viruses can cause cold-like symptoms. So how do you know which one you’ve got? Remind me, how...